$9.48B in CY2024 Part D spend10.0M claims · 2.5M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Rivaroxaban used for?
Rivaroxaban prevents blood clots by inhibiting factor Xa, prescribed for atrial fibrillation and venous thromboembolism.
Is there a generic for Rivaroxaban?
Yes. 58 ANDAs filed at FDA, 17 generic manufacturers currently shipping.
How much does my plan pay for Rivaroxaban?
Across 329 Part D plans, Rivaroxaban averages $1.03/unit (NADAC). Lowest available: $0.979/unit. Highest in distribution: $1.96/unit.
Is Rivaroxaban on the FDA shortage list?
No. Rivaroxaban is not currently on the FDA Drug Shortage Database.
8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.